VOLUME 4 ISSUE 8: Mark Beeston, Vice President , Sales and Marketing, Viogaurd Discusses Killing Germs in a COVID-19 Era

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Mark Beeston, Vice President, Sales and Marketing, Viogaurd, a company developing products that enhance the effectiveness of infection control strategies. In this interview, Beeston discusses using UV technology to kill germs. This issue also brings you news on digital

Industry News: VOLUME 4 ISSUE 9

More Consolidation, IPOs Ahead for Digital Health Companies By Fenwick & West LLP Lexology.com - Virtual healthcare staked out exciting new ground with the recently announced $18.5 billion merger of telemedicine pioneer Teladoc Health and chronic disease management company Livongo. The deal illustrates the growing appetite among public-market investors for innovative healthcare solutions. To view the

VOLUME 4 ISSUE 8: Doug Geinzer, Founder and President, High Performance Providers Discusses Measuring Quality and Saving Plans 40-60% of Health Spend.

Dear Colleagues, Medical Travel Today is excited to bring you an interview with Doug Geinzer, Founder and President, High Performance Providers, a company working closely with self-funded health plans, third-party administrators (TPAs) that represent the plans, their consultants and the high-performance networks they seek out. In this interview, Geinzer discusses his

Spotlight Interview: Doug Geinzer, Founder and President, High Performance Providers

About Doug Geinzer Doug is the founder/president of High Performance Providers, a boutique consulting firm that works with world-class surgeons looking to contract with self-funded health plans. He only represents surgeons that deliver better health outcome for a lower/bundled price. While CEO of Las Vegas HEALS (Healthcare | Education | Advocacy

Industry News: VOLUME 4 ISSUE 8

Telehealth leader Teladoc to buy Livongo in $18.5B deal by Heather Landi Fiercehealthcare.com - Telehealth giant Teladoc is acquiring virtual care company Livongo in a deal valued at $18.5 billion. The deal would combine one of the leaders in the telehealth market with a growing digital health firm that targets chronic disease management. To

VOLUME 4 ISSUE 7: Kevin Cast, Partner, Archbow Consulting, Discusses Specialty Pharmacy and Personalized Medicine

Dear Colleagues, In this issue, I had the chance to speak with Kevin Cast, Partner, Archbow Consulting, a company helping pharma and biotech companies design, build, and optimize product distribution and patient access strategies. In this interview, Cast explains specialty pharmacy in the era of COVID-19 and how companies can best

Spotlight Interview: Kevin Cast, Partner, Archbow Consulting

About Kevin Cast Kevin Cast's career in the pharmaceutical and biotech industry includes experience in pharma companies, PBMs, service providers, and specialty pharmacies over three decades. Today, as a founding partner of Archbow Consulting, Kevin develops unique strategies to maximize the current supply/service chain, while considering trends that predict future needs.

Industry News: VOLUME 4 ISSUE 7

NeuroOne Medical Technologies Corporation Enters into Exclusive Development and Distribution Agreement for Commercialization of Diagnostic EVO Cortical Electrode Eden Prairie, MN– July 22, 2020– NeuroOne Medical Technologies Corporation (OTCQB: NMTC), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announces the execution

VOLUME 4 ISSUE 6: Brian Klepper, Principal, Worksite Health Advisors, Discusses High Performing Health Organizations

Dear Colleagues, In this issue, I had the chance to speak with Brian Klepper, Principal, Worksite Health Advisors, a company finding and vetting health care companies that consistently deliver measurably better health outcomes at far lower costs than conventional approaches. In this interview, Klepper explains the benefits of using high-performing organizations,